• 1
    Wolfe F. Comparative usefulness of C-reactive protein and erythrocyte sedimentation rate in patients with rheumatoid arthritis. J Rheumatol 1997; 24: 147785.
  • 2
    Del Rincón I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 273745.
  • 3
    Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984: 27: 86472.
  • 4
    Mitchell DM, Spitz PW, Young DY, Bloch DA, McShane DJ, Fries JF, et al. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29: 70614.
  • 5
    Jacobsson LT, Knowler WC, Pillemer S, Hanson RL, Pettitt DJ, Nelson RG, et al. Rheumatoid arthritis and mortality: a longitudinal study in Pima Indians. Arthritis Rheum 1993; 36: 104553.
  • 6
    Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994; 37: 48194.
  • 7
    Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Isomaki H. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol 1995; 22: 10657.
  • 8
    Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP, et al. Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 2002; 46: 20109.
  • 9
    Ross R. Atherosclerosis—an inflammatory disease. N Engl J Med 1999; 340: 11526.
  • 10
    Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 9739.
  • 11
    Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996; 144: 53747.
  • 12
    Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99: 23742.
  • 13
    Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000; 59: 3215.
  • 14
    Van Doornum S, McColl G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 86273.
  • 15
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 16
    Escalante A, del Rincón I. How much disability in rheumatoid arthritis is explained by rheumatoid arthritis? Arthritis Rheum 1999; 42: 171221.
  • 17
    Del Rincón I, Battafarano DF, Arroyo RA, Murphy FT, Escalante A. Heterogeneity between men and women in the influence of the HLA–DRB1 shared epitope on the clinical expression of rheumatoid arthritis. Arthritis Rheum 2002; 46: 14808.
  • 18
    NHLBI Communications Office. NHLBI launches 10-year study on early detection of heart disease. Accessed September 14, 2000. URL:
  • 19
    O'Leary DH, Polak JF, Wolfson SK Jr, Bond MG, Bommer W, Sheth S, et al, the CHS Collaborative Research Group. Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 1991; 22: 115563.
  • 20
    Rogers WH. Sg17: regression standard errors in clustered samples. Stata Technical Bulletin 1993; STB-13: 1923.
  • 21
    Rothman KJ, Greenland S. Causation and causal inference. In: RothmanKJ, GreenlandS, editors. Modern epidemiology. Philadelphia: Lippincott-Raven; 1998. p. 728.
  • 22
    Park YB, Ahn CW, Choi HK, Lee SH, In BH, Lee HC, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46: 17149.
  • 23
    Jonsson SW, Backman C, Johnson O, Karp K, Lundström E, Sundqvist KG, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: 2597602.
  • 24
    Kumeda Y, Inaba M, Goto H, Nagata M, Henmi Y, Furumitsu Y, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 148997.
  • 25
    O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, the Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 1422.
  • 26
    O'Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, et al, the Cardiovascular Health Study Collaborative Research Group. Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke 1996; 27: 22431.
  • 27
    Kushner I. Erythrocyte sedimentation rate and the acute phase response. In: KelleyWN, HarrisEDJr, RuddyS, SledgeCB, editors. Textbook of rheumatology. Philadelphia: WB Saunders; 1989. p. 71927.
  • 28
    Esmon CT. Does inflammation contribute to thrombotic events? Haemostasis 2000; 30 Suppl 2: 3440.
  • 29
    Blackburn WD Jr. Validity of acute phase proteins as markers of disease activity. J Rheumatol Suppl 1994; 42: 913.
  • 30
    Volanakis JE. Human C-reactive protein: expression, structure and function. Mol Immunol 2001; 38: 18997.
  • 31
    Akira S, Kishimoto T. IL-6 and NF-IL6 in acute-phase response and viral infection. Immunol Rev 1992; 127: 2550.
  • 32
    Torzewski J, Torzewski M, Bowyer DE, Frohlich M, Koenig W, Waltenberger J, et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 138692.
  • 33
    Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999; 100: 21359.
  • 34
    Young W, Gofman JW, Tandy R, Malamud N, Waters ESG. The quantification of atherosclerosis. III. The extent of correlation of degrees of atherosclerosis within and between the coronary and cerebral vascular beds. Am J Cardiol 1960; 6: 3008.
  • 35
    Persson J, Formgren J, Israelsson B, Berglund G. Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thromb 1994; 14: 2614.
  • 36
    O'Leary DH, Polak JF, Kronmal RA, Kittner SJ, Bond MG, Wolfson SK Jr, et al, the CHS Collaborative Research Group. Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke 1992; 23: 175260.
  • 37
    Newman TB, Browner WS, Hulley SB. Enhancing causal inference in observational studies. In: HulleySB, CummingsSR, BrownerWS, GradyD, HearstN, NewmanTB, editors. Designing clinical research. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 12538.